Chicago Partners Investment Group LLC Buys 943 Shares of Colgate-Palmolive (NYSE:CL)

Chicago Partners Investment Group LLC grew its stake in Colgate-Palmolive (NYSE:CLFree Report) by 16.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,752 shares of the company’s stock after acquiring an additional 943 shares during the period. Chicago Partners Investment Group LLC’s holdings in Colgate-Palmolive were worth $591,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the third quarter worth approximately $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the third quarter worth approximately $53,000. Synergy Asset Management LLC bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $49,000. Finally, Prospera Private Wealth LLC bought a new position in Colgate-Palmolive in the third quarter worth approximately $64,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $87.05 on Tuesday. The business’s fifty day simple moving average is $91.35 and its 200-day simple moving average is $97.15. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The firm has a market cap of $71.12 billion, a PE ratio of 24.73, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the company posted $0.87 EPS. Equities analysts forecast that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Raymond James restated an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday. Finally, TD Cowen cut their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $101.16.

Check Out Our Latest Analysis on CL

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.